Jeffrey Hobbs
Direktor/Vorstandsmitglied bei Ferring International Center SA
Profil
Jeffrey David Hobbs is currently the Vice Chairman at Ferring International Center SA since 1994 and the Director at Esperante Ltd.
since 2007.
Previously, he held the position of Vice Chairman at Ferring Holding SA. He also served as the Director at Ferring Pharmaceuticals Ltd.
from 1994 to 2004.
Mr. Hobbs completed his undergraduate degree at the University of London.
Aktive Positionen von Jeffrey Hobbs
| Unternehmen | Position | Beginn |
|---|---|---|
Ferring International Center SA
 Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Direktor/Vorstandsmitglied | 01.01.1994 |
Esperante Ltd.
 Esperante Ltd. Investment ManagersFinance Esperante Ltd. operates as a venture investment company controlled by C&P Group Holdings. The company was founded on April 29, 1986 and is headquartered in Maidenhead, the United Kingdom. | Direktor/Vorstandsmitglied | 28.07.2007 |
Ehemalige bekannte Positionen von Jeffrey Hobbs
| Unternehmen | Position | Ende |
|---|---|---|
Ferring Holding SA
 Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland. | Direktor/Vorstandsmitglied | 08.04.2024 |
Ferring Pharmaceuticals Ltd.
 Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Direktor/Vorstandsmitglied | 22.03.2004 |
Ausbildung von Jeffrey Hobbs
| University of London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
Ferring Holding SA
Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
Ferring Pharmaceuticals Ltd.
Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Health Technology |
Esperante Ltd.
Esperante Ltd. Investment ManagersFinance Esperante Ltd. operates as a venture investment company controlled by C&P Group Holdings. The company was founded on April 29, 1986 and is headquartered in Maidenhead, the United Kingdom. | Finance |
